GHA
AGN

GW Henssler & Associates’s Allergan plc AGN Stock Holding History

GW Henssler & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,773
Closed -$237K – 205
2018
Q4 		$237K Sell
1,773
-45
-2% -$7.38K 0.03% 116
2018
Q3 		$346K Buy
+1,818
New +$334K 0.03% 112

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GW Henssler & Associates's AGN Position: Q1 2019 in Review

GW Henssler & Associates sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 1,773 shares — an estimated $237K sold.

GW Henssler & Associates first reported a position in AGN in Q3 2018 and held it in 2 quarters. The position peaked at $346K in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • GW Henssler & Associates reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • GW Henssler & Associates sold 1,773 Allergan plc shares in Q1 2019, an estimated $237K.
  • GW Henssler & Associates first reported a position in Allergan plc in Q3 2018 and held it in 2 quarters.
  • GW Henssler & Associates's Allergan plc position peaked at $346K in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on GW Henssler & Associates's 13F filing for Q1 2019, filed 15 May 2019.